Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: John Milligan

Premium

Pacific Biosciences has appointed John Milligan to its board of directors. Milligan is currently President and COO of Gilead Sciences. He has been at Gilead since 1990, and has served a variety of roles, including research scientist and chief financial officer. He holds a BA from Ohio Wesleyan University and a PhD from the University of Illinois.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.